GANX RSI Chart
Last 7 days
3.2%
Last 30 days
-18.5%
Last 90 days
-46.3%
Trailing 12 Months
-45.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 150.3K | 55.2K | 55.2K | 55.2K |
2022 | 204.7K | 210.7K | 183.3K | 140.1K |
2021 | 27.5K | 110.3K | 130.9K | 165.0K |
2020 | 0 | 0 | 0 | 28.9K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 28, 2024 | riley jeffrey scott | bought | 115,770 | 3.859 | 30,000 | - |
Mar 26, 2024 | alder matthias | sold (taxes) | -24,705 | 4.06 | -6,085 | chief executive officer |
Mar 26, 2024 | alder matthias | acquired | - | - | 20,212 | chief executive officer |
Dec 21, 2023 | alder matthias | sold | -506 | 2.46 | -206 | chief executive officer |
Dec 20, 2023 | alder matthias | acquired | - | - | 637 | chief executive officer |
Dec 07, 2023 | alder matthias | sold | -4,550 | 2.5 | -1,820 | chief executive officer |
Oct 01, 2023 | alder matthias | acquired | - | - | 825 | chief executive officer |
Sep 20, 2023 | richman eric i | acquired | - | - | 54,900 | - |
Sep 20, 2023 | alder matthias | acquired | - | - | 2,550 | chief executive officer |
Jul 01, 2023 | alder matthias | acquired | - | - | 3,300 | chief executive officer |
Which funds bought or sold GANX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Creekmur Asset Management LLC | unchanged | - | 2,242 | 16,739 | 0.01% |
May 15, 2024 | Royal Bank of Canada | added | 24.1 | 283,000 | 937,000 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -93.54 | -197,591 | 15,921 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | reduced | -34.92 | -37,417 | 113,100 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 247 | 125,774 | 167,448 | -% |
May 15, 2024 | PRELUDE CAPITAL MANAGEMENT, LLC | reduced | -38.35 | -54,656 | 135,041 | 0.01% |
May 15, 2024 | DME Capital Management, LP | new | - | 2,134,310 | 2,134,310 | 0.10% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -5.31 | 1,491 | 17,463 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 12,724 | 12,724 | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | 1,414 | 10,556 | -% |
Peers (Alternatives to Gain Therapeutics, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Gain Therapeutics, Inc. News
Income Statement (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
Revenue | - | - | - | - | 55,180 | - | - | 95,102 | 45,006 | 43,208 | 27,345 | 89,173 | 5,269 | 9,139 | 6,696 | 6,373 | 6,673 |
Operating Expenses | -9.8% | 4,407,230 | 4,885,005 | 7,731,114 | 5,284,964 | 4,561,199 | 4,750,984 | 5,271,487 | 3,333,483 | 3,251,977 | 4,663,270 | 3,603,736 | 2,472,184 | 1,624,774 | 825,785 | 538,838 | 518,933 |
S&GA Expenses | -19.2% | 2,033,247 | 2,517,523 | 3,743,171 | 2,493,759 | 2,287,357 | 2,786,200 | 2,689,263 | 1,777,043 | 1,779,504 | 2,186,531 | 1,810,228 | 1,050,675 | 649,162 | 398,320 | 99,970 | 101,674 |
R&D Expenses | 0.3% | 2,373,983 | 2,367,482 | 3,987,943 | 2,791,205 | 2,273,842 | 1,964,784 | 2,582,224 | 1,556,440 | 1,472,473 | 2,476,739 | 1,793,508 | 1,421,509 | 975,612 | 427,465 | 438,868 | 417,259 |
EBITDA Margin | -0.8% | -391 | -388 | -385 | -124 | -121 | -86.55 | -76.58 | -71.71 | -83.99 | -93.82 | -76.40 | - | - | - | - | - |
Interest Expenses | 0.3% | 106,270 | 106,000 | 129,929 | 152,035 | 163,777 | 153,332 | 59,899 | -1,651 | 267 | 4,918 | 5,901 | 1,408 | 6,895 | 7.00 | -1,517 | -1,747 |
Income Taxes | -32.4% | 14,502 | 21,456 | 26,589 | 16,728 | 78,105 | 4,048 | 9,146 | 1,677 | -8,244 | 5,114 | 3,660 | 3,479 | -1,368 | 885 | 4,523 | 1,347 |
Earnings Before Taxes | -0.3% | -4,709,467 | -4,696,807 | -7,661,380 | -5,120,591 | -4,596,361 | -4,554,161 | -5,076,274 | -3,270,966 | -3,228,177 | -4,658,419 | -3,553,033 | -2,446,968 | -1,657,049 | -793,486 | -538,839 | -582,921 |
EBT Margin | -0.5% | -402 | -400 | -397 | -128 | -124 | -87.99 | -77.06 | -71.85 | -84.16 | -94.06 | -76.63 | - | - | - | - | - |
Net Income | -0.1% | -4,723,969 | -4,718,263 | -7,687,969 | -5,137,319 | -4,674,466 | -4,558,209 | -5,085,420 | -3,272,643 | -3,219,933 | -4,663,533 | -3,556,693 | -2,450,447 | -1,655,681 | -794,371 | -543,362 | -584,268 |
Net Income Margin | -0.2% | -403 | -402 | -399 | -129 | -125 | -88.02 | -77.10 | -71.86 | -84.19 | -94.15 | -76.69 | - | - | - | - | - |
Free Cashflow | -40.7% | -5,660,379 | -4,023,894 | -5,078,543 | -4,274,594 | -3,961,792 | -3,346,255 | -5,095,610 | -2,455,216 | -4,157,463 | -2,224,461 | -3,239,563 | - | - | - | - | - |
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | -21.7% | 14,577 | 18,609 | 14,097 | 18,261 | 21,323 | 24,099 | 28,326 | 31,890 | 37,599 | 38,985 | 42,562 | 45,353 | 48,041 | 9,604 |
Current Assets | -22.0% | 13,863 | 17,779 | 13,242 | 17,308 | 19,322 | 21,091 | 24,349 | 25,833 | 36,392 | 37,722 | 41,555 | 44,335 | 47,384 | 8,988 |
Cash Equivalents | -9.5% | 10,673 | 11,795 | 4,273 | 6,320 | 5,988 | 7,312 | 10,909 | 14,336 | 34,369 | 36,912 | 41,015 | 43,205 | 46,636 | 7,504 |
Net PPE | -11.2% | 112 | 126 | 127 | 139 | 145 | 144 | 137 | 139 | 107 | 106 | 103 | 75.00 | 55.00 | 30.00 |
Liabilities | -1.6% | 5,935 | 6,031 | 6,767 | 7,168 | 6,184 | 5,220 | 5,663 | 4,873 | 5,771 | 4,168 | - | - | - | 3,402 |
Current Liabilities | 1.1% | 5,004 | 4,950 | 5,763 | 5,588 | 5,155 | 4,125 | 4,332 | 3,410 | 4,217 | 2,553 | 3,577 | 2,451 | 2,327 | 2,115 |
Long Term Debt | -11.6% | 397 | 449 | 435 | 467 | 478 | 495 | 484 | 542 | 561 | 590 | 620 | 647 | 678 | 716 |
LT Debt, Current | -6.7% | 111 | 119 | 109 | 112 | 109 | 108 | 101 | 84.00 | 87.00 | 104 | 87.00 | 65.00 | 44.00 | 23.00 |
LT Debt, Non Current | -100.0% | - | 449 | 435 | 467 | 478 | 495 | 484 | 542 | 561 | 590 | 620 | 647 | 678 | 716 |
Shareholder's Equity | -31.3% | 8,642 | 12,578 | 7,331 | 11,093 | 15,139 | 18,880 | 22,663 | 27,017 | 31,828 | 34,818 | 37,545 | 41,389 | 44,464 | 6,202 |
Retained Earnings | -57.8% | -60,783 | -38,516 | - | - | -38,516 | -20,925 | -20,925 | -20,925 | -20,925 | -7,034 | -7,034 | -7,034 | -7,034 | -3,457 |
Additional Paid-In Capital | 0.4% | 73,416 | 73,113 | 63,299 | 62,299 | 58,695 | 57,359 | 56,800 | 56,445 | 56,139 | 55,832 | 55,362 | 54,594 | 54,105 | 13,389 |
Shares Outstanding | 11.3% | 18,041 | 16,207 | 12,783 | 12,632 | 12,087 | 11,883 | 11,883 | 11,883 | 11,883 | 11,883 | 9,587 | 11,876 | - | - |
Float | - | - | - | - | 56,600 | - | - | - | 38,800 | - | - | - | 118,700 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
Cashflow From Operations | 36.6% | -3,586 | -5,660 | -3,966 | -5,021 | -4,217 | -3,904 | -3,289 | -5,051 | -2,447 | -4,146 | -2,192 | -3,217 | -2,809 | -1,308 | -755 | -424 | -752 |
Share Based Compensation | -65.7% | 190 | 555 | 907 | 1,231 | 565 | 559 | 356 | 306 | 307 | 286 | 251 | 192 | 111 | - | - | - | - |
Cashflow From Investing | -3.9% | 3,019 | 3,142 | 1,929 | 3,045 | 2,107 | 134 | -11.41 | -14,889 | -7.82 | -11.10 | -32.12 | -22.50 | -28.49 | -14.55 | -1.42 | 38* | -4.90 |
Cashflow From Financing | -101.5% | -145 | 9,561 | 134 | 2,197 | 749 | -21.58 | -20.58 | 1.00 | -37.97 | -9.73 | - | -213 | 41,990 | -440 | 9,545 | -10.55 | 1,393 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Collaboration revenues | $ 55,180 | |
Total revenues | 55,180 | |
Operating expenses: | ||
Research and development | $ (2,506,906) | (2,791,205) |
General and administrative | (1,870,794) | (2,493,759) |
Total operating expenses | (4,377,700) | (5,284,964) |
Loss from operations | (4,377,700) | (5,229,784) |
Other income/(expense): | ||
Interest income, net | 115,303 | 152,035 |
Foreign exchange gain/(loss), net | 268,077 | (42,842) |
Loss before income tax | (3,994,320) | (5,120,591) |
Income tax | (19,874) | (16,728) |
Net loss | $ (4,014,194) | $ (5,137,319) |
Net loss per shares: | ||
Net loss per share attributable to common stockholders - Basic | $ (0.22) | $ (0.43) |
Net loss per share attributable to common stockholders - Diluted | $ (0.22) | $ (0.43) |
Weighted average common shares - Basic | 17,978,951 | 11,935,081 |
Weighted average common shares - Diluted | 17,978,951 | 11,935,081 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 10,641,087 | $ 11,794,949 |
Marketable securities - current | 2,019,414 | 4,999,704 |
Tax credits | 249,133 | 242,577 |
Prepaid expenses and other current assets | 952,889 | 741,638 |
Total current assets | 13,862,523 | 17,778,868 |
Non-current assets: | ||
Property and equipment, net | 111,909 | 125,962 |
Internal-use software | 169,249 | 193,375 |
Operating lease - right of use assets | 384,146 | 459,215 |
Restricted cash | 31,744 | 34,021 |
Long-term deposits and other non-current assets | 17,613 | 17,890 |
Total non-current assets | 714,661 | 830,463 |
Total assets | 14,577,184 | 18,609,331 |
Current liabilities: | ||
Accounts payable | 1,405,154 | 1,318,965 |
Operating lease liability - current | 204,569 | 229,693 |
Other current liabilities | 2,368,806 | 2,160,366 |
Deferred income - current | 914,759 | 1,122,138 |
Loans - current | 110,848 | 118,797 |
Total current liabilities | 5,004,136 | 4,949,959 |
Non-current liabilities: | ||
Defined benefit pension plan | 292,486 | 307,454 |
Operating lease liability - non-current | 177,365 | 229,855 |
Deferred income - non-current | 64,300 | 94,786 |
Loans - non-current | 396,836 | 449,053 |
Total non-current liabilities | 930,987 | 1,081,148 |
Total liabilities | 5,935,123 | 6,031,107 |
Stockholders' equity | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; nil shares issued and outstanding as of March 31, 2024 and December 31, 2023. | 0 | 0 |
Common stock, $0.0001 par value: 50,000,000 shares authorized; 18,041,231 issued and outstanding as of March 31, 2024; 16,206,680 issued and outstanding as of December 31, 2023. | 1,805 | 1,621 |
Additional paid-in capital | 73,416,304 | 73,113,079 |
Accumulated other comprehensive income | 21,863 | 247,241 |
Accumulated deficit | (60,783,717) | (38,516,197) |
Loss for the period | (4,014,194) | (22,267,520) |
Total stockholders' equity | 8,642,061 | 12,578,224 |
Total liabilities and stockholders' equity | $ 14,577,184 | $ 18,609,331 |